Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Glucagon-like peptide-1 (GLP-1) receptor agonists were originally developed to treat diabetes and were found to cause weight loss in patients taking them
Cardiovascular Benefits: GLP-1 drugs may offer additional protection against heart disease, a crucial consideration for psoriasis and PsA patients
Looking ahead, innovation, personalized medicine, and patient-centric solutions are expected to shape the future of this dynamic market
You can learn more about how these treatments work on our how it works page
I attended a live taping of the podcast episode (and got some one-on-one time with Williams right after)
US$ 21.25
US$ 25.56
US$ 25.77
US$ 21.52
